- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04792255
Digital Variance Angiography for Contrast Media Dose Reduction in Carotid Artery Stenting
Investigation of Dose Management Capabilities of Digital Variance Angiography: Contrast Media Dose Reduction in Patients Undergoing Carotid Artery Stenting - a Prospective Randomized Clinical Trial
Digital Variance Angiography (DVA) is a new tool in medical imaging with a proven image quality reserve (1, 2).
Previous studies have demonstrated the quality reserve of DVA in angiographic studies (1, 2), which allowed us to reduce contrast media use by 50% in carotid artery angiographic studies without affecting the image quality (3).
CAS is an alternative treatment option for carotid artery revascularization in selected patient groups. Similar to most of the minimally invasive endovascular interventions, CAS also carries the risk of contrast-induced acute kidney injury, which is considered to be an independent predictor of 30-day major adverse events (4).
The aim of this study is to apply DVA in patients undergoing carotid artery stenting (CAS) and utilize this technique to reduce contrast dose during the interventions, without affecting the intraprocedural radiation dose and the clinical outcome of the procedures. Investigators believe that the reduction in contrast media use and the associated image quality with the technique of DVA imaging can be incorporated into the everyday clinical practice, and will play an important role in improving the rate of contrast-induced acute kidney injury.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Péter Sótonyi, MD, PhD
- Phone Number: +36 20 825 8046
- Email: sotonyi@hotmail.com
Study Contact Backup
- Name: Peter T Legeza, MD
- Phone Number: +36 20 825 9736
- Email: peterlegeza@gmail.com
Study Locations
-
-
-
Budapest, Hungary, 1122
- Recruiting
- Semmelweis University, Heart and Vascular Center
-
Contact:
- Péter Sótonyi, Prof,MD,PhD
-
Contact:
- Balázs Nemes, MD,PhD
-
Sub-Investigator:
- Márton Berczeli, M.D.
-
Sub-Investigator:
- Marcell Gyánó, M.D.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age > 18 y
- Carotid stenosis defined as:
Stenosis ≥70% by computer tomography angiography (NASCET criteria); OR by duplex-ultrasound with ≥70% stenosis defined by a peak systolic velocity of at least 230 cm/s
- Carotid stenosis is treatable with CAS
Exclusion Criteria:
- History of stroke or TIA ipsilateral to the stenosis within 30 days of randomization
- Acute myocardial infarction
- Severe chronic kidney disease: GFR>30ml/min/m2
- Severe heart failure: NYHA IV
- Severe liver failure: Child-Pugh 3
- Iodine contrast allergy
- Coagulopathy
- Hematological bleeding disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A: Reduced contrast media dose group
Reduced contrast media protocol: extracranial carotid artery intervention (2-4 fps according to the institutional protocol). Contrast administration with an automatic contrast injector: angiographic image acquisitions will be performed with 6 ml of 50% contrast media (3 ml iodined contrast media, 3 ml physiologic saline) with a 3 ml/s flow rate. DSA and DVA images will be calculated; DVA images will be used for diagnosis and interventions. |
Radial, brachial or femoral arterial access is gained by using the Seldinger technique.
The common carotid artery (CCA) is catheterized.
Selective angiography is performed from the anteroposterior and lateral view without magnification.
Initial angiograms are performed with the reduced contrast media protocol in anteroposterior and lateral views without magnification with the sheath placed in the common carotid artery.
The carotid arterial lesion is crossed and an embolic protection device is deployed in the internal carotid artery.
Carotid artery stenting is performed in a standard fashion.
Post-stenting angiographies are obtained with the reduced contrast media protocol in anteroposterior and lateral views without magnification with the sheath placed in the CCA.
Pre- and post-stenting angiographies are performed with the same sheath position.
DSA and DVA images will be calculated on a commercially available image processing workstation and the Kinepict Medical Imaging Tool.
Other Names:
Pre- and postinterventional assessment of the treated internal carotid artery.
|
|
Active Comparator: Group B: Standard contrast media dose group
Standard contrast media protocol: extracranial carotid artery intervention (2-4 fps according to the institutional protocol). Contrast administration with an automatic contrast injector: angiographic image acquisitions will be performed with 6 ml iodined contrast media with a 3 ml/s flow rate. DSA and DVA images will be calculated; DSA images will be used for diagnosis and interventions. |
Pre- and postinterventional assessment of the treated internal carotid artery.
Radial, brachial or femoral arterial access is gained by using the Seldinger technique.
The common carotid artery (CCA) is catheterized.
Selective angiography is performed from the anteroposterior and lateral view without magnification.
Initial angiograms are performed with standard contrast media protocol in anteroposterior and lateral views without magnification with the sheath placed in the common carotid artery.
The carotid arterial lesion is crossed and an embolic protection device is deployed in the internal carotid artery.
Carotid artery stenting is performed in a standard fashion.
Post-stenting angiographies are obtained with the standard contrast media protocol in anteroposterior and lateral views without magnification with the sheath placed in the CCA.
Pre- and post-stenting angiographies are performed with the same sheath position.
DSA and DVA images will be calculated on a commercially available image processing workstation and the Kinepict Medical Imaging Tool.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
DSA-related contrast media use
Time Frame: During the procedure
|
Volume of the iodinated contrast agent used for enhancing the image quality (mL)
|
During the procedure
|
|
Total procedural contrast media use
Time Frame: During the procedure
|
Volume of the iodinated contrast agent used for enhancing the image quality (mL)
|
During the procedure
|
|
Image quality, graded by independent observers
Time Frame: through study completion, an average of 1 year
|
Observations based on a 5-level Likert scale (1-poor image quality, 3-medium image quality, 5-outstanding image quality)
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total procedural dose area product
Time Frame: During the procedure
|
Indicator of a patient's irradiation dosage (microGy*cm2 or Gy*cm2)
|
During the procedure
|
|
DSA-related dose area product
Time Frame: During the procedure
|
Indicator of a patient's irradiation dosage (microGy*cm2 or Gy*cm2)
|
During the procedure
|
|
Total procedural time
Time Frame: During the procedure
|
Duration of the whole procedure, from arterial access till the removal of every tool (min)
|
During the procedure
|
|
Number of protocol changes during DVA usage
Time Frame: During the procedure
|
Number of occasions when the reduced contrast media protocol has to be switched back to conventional protocol because of the unsuitable image quality
|
During the procedure
|
|
Residual stenosis
Time Frame: During the procedure
|
The difference between the normal reference segment diameter and the minimum lumen diameter of the treated lesion after CAS (%)
|
During the procedure
|
|
Focal neurological symptoms
Time Frame: During the procedure and up to 1 day
|
Focal neurological symptoms ipsilateral to the treated carotid artery during the postprocedural observation period
|
During the procedure and up to 1 day
|
|
Preoperative and postoperative ipsilateral carotid artery flow by doppler ultrasound
Time Frame: Preoperatively and 1 day after the procedure
|
Peak-systolic and end-diastolic velocities (cm/sec)
|
Preoperatively and 1 day after the procedure
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Orias VI, Gyano M, Gog I, Szollosi D, Veres DS, Nagy Z, Csobay-Novak C, Zoltan O, Kiss JP, Osvath S, Szigeti K, Zoltan R, Sotonyi P. Digital Variance Angiography as a Paradigm Shift in Carbon Dioxide Angiography. Invest Radiol. 2019 Jul;54(7):428-436. doi: 10.1097/RLI.0000000000000555.
- Gyano M, Gog I, Orias VI, Ruzsa Z, Nemes B, Csobay-Novak C, Olah Z, Nagy Z, Merkely B, Szigeti K, Osvath S, Sotonyi P. Kinetic Imaging in Lower Extremity Arteriography: Comparison to Digital Subtraction Angiography. Radiology. 2019 Jan;290(1):246-253. doi: 10.1148/radiol.2018172927. Epub 2018 Oct 16.
- Orias VI, Szollosi D, Gyano M, Veres DS, Nardai S, Csobay-Novak C, Nemes B, Kiss JP, Szigeti K, Osvath S, Sotonyi P, Ruzsa Z. Initial evidence of a 50% reduction of contrast media using digital variance angiography in endovascular carotid interventions. Eur J Radiol Open. 2020 Nov 17;7:100288. doi: 10.1016/j.ejro.2020.100288. eCollection 2020.
- Paraskevas KI, Mikhailidis DP. Contrast-Induced Acute Kidney Injury in Patients Undergoing Carotid Artery Stenting: An Underestimated Issue. Angiology. 2017 Oct;68(9):752-756. doi: 10.1177/0003319716668934. Epub 2016 Sep 19.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Kinepict-009
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carotid Artery Diseases
-
Acandis GmbHRecruitingCarotid Artery Stenting | Carotid Artery Disease | Embolic Stroke of Undetermined Source | Carotid Artery Thrombosis | Carotid Plaque Imaging | Symptomatic Carotid Artery StenosisGermany
-
Beijing Tiantan HospitalShanghai HeartCare Medical Technology Co., Ltd.RecruitingCarotid Artery Stenting | Carotid Artery StenosisChina
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); Cedars-Sinai Medical Center and other collaboratorsRecruitingCarotid Atherosclerosis | Asymptomatic Carotid Artery Stenosis | Carotid Artery AtheromaUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingOxidative Stress | Carotid Artery Stenosis Asymptomatic | Carotid Artery Stenosis Symptomatic | vonWillebrand Disease
-
Xuanwu Hospital, BeijingRecruitingCarotid Artery Plaque | Carotid Artery Stenting | Carotid EndarterectomyChina
-
Xuanwu Hospital, BeijingChanghai Hospital; Peking Union Medical College Hospital; The Second Hospital... and other collaboratorsRecruitingCarotid Artery Stenting | Carotid Endarterectomy | Best Medical Treatment | Carotid Artery Stenosis AsymptomaticChina
-
Heinrich-Heine University, DuesseldorfRecruitingCarotid Artery Plaque | Carotid Artery Diseases | Carotid Artery Stenosis Asymptomatic | Carotid Artery StenosisGermany
-
Medical University of SilesiaSilesian University of MedicineUnknown
-
Contego Medical, Inc.Completed
-
Oslo University HospitalCompletedCarotid Artery Stenoses
Clinical Trials on Carotid artery stenting with reduced contrast media protocol
-
Universität des SaarlandesUnknownCarotid Artery StenosisGermany
-
Providence Health & ServicesCompleted
-
Abbott Medical DevicesTerminatedStroke | Atherosclerosis | Carotid Stenosis | Carotid Artery DiseaseUnited States
-
Abbott Medical DevicesCompletedStroke | Atherosclerosis | Carotid Stenosis | Carotid Artery Disease
-
Contego Medical, Inc.IQVIA Pty Ltd; Yale Cardiovascular Research Group; Medidata Solutions; CardioMed... and other collaboratorsActive, not recruitingCarotid Stenosis | Carotid Artery Diseases | Carotid Artery StenosisUnited States, Germany, Italy, Slovenia, Bulgaria, North Macedonia
-
Contego Medical, Inc.Completed
-
John Paul II Hospital, KrakowRecruitingMyocardial Infarction | Coronary Artery Disease | Carotid Stenosis | Valvular Heart Disease | Pulmonary Edema With Heart FailurePoland
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingAdult T Acute Lymphoblastic Leukemia | Childhood T Acute Lymphoblastic Leukemia | Ann Arbor Stage II Adult Lymphoblastic Lymphoma | Ann Arbor Stage II Childhood Lymphoblastic Lymphoma | Ann Arbor Stage III Adult Lymphoblastic Lymphoma | Ann Arbor Stage III Childhood Lymphoblastic Lymphoma | Ann... and other conditionsUnited States, Canada, Australia, New Zealand